Ovation Science (XCNQ:OVAT) LT-Debt-to-Total-Asset : 0.51 (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ovation Science LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Ovation Science's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.51.

Ovation Science's long-term debt to total assets ratio declined from Jun. 2023 (0.91) to Jun. 2024 (0.51). It may suggest that Ovation Science is progressively becoming less dependent on debt to grow their business.

Ovation Science LT-Debt-to-Total-Asset Historical Data

The historical data trend for Ovation Science's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science LT-Debt-to-Total-Asset Chart

Ovation Science Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.17

0.23

Ovation Science Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.91	0.83	0.23	-	0.51

Ovation Science LT-Debt-to-Total-Asset Calculation

Ovation Science's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.018	/	0.077
	=	0.23

Ovation Science's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	0.043	/	0.084
	=	0.51

Ovation Science (XCNQ:OVAT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Ovation Science LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Ovation Science's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovation Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

OVATF:USA 0VH:Germany

Address

625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6

Website

https://www.ovationscience.com

Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.

Executives

David K. Ryan

Director

Ovation Science Headlines

No Headlines